Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DXCM – DexCom, Inc.

DexCom, Inc.
DXCM
$66.37
Name : DexCom, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $26,027,345,920.00
EPSttm : 1.8
finviz dynamic chart for DXCM
DexCom, Inc.
$66.37
1.03%
$0.69

Float Short %

3.41

Margin Of Safety %

12

Put/Call OI Ratio

0.67

EPS Next Q Diff

-0.14

EPS Last/This Y

0.6

EPS This/Next Y

0.41

Price

66.38

Target Price

86.42

Analyst Recom

1.42

Performance Q

0.44

Relative Volume

0.35

Beta

1.49

Ticker: DXCM




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-02DXCM64.450.680.84191532
2025-12-03DXCM64.830.682.61193897
2025-12-04DXCM65.270.6810.25194006
2025-12-05DXCM65.50.671.07195049
2025-12-08DXCM65.650.674.48194015
2025-12-09DXCM66.320.661.08194802
2025-12-10DXCM67.540.661.14195978
2025-12-11DXCM68.930.662.28196684
2025-12-12DXCM66.940.671.67197886
2025-12-15DXCM65.710.670.86196411
2025-12-16DXCM66.380.670.76197177
2025-12-17DXCM65.760.670.27198127
2025-12-18DXCM65.880.672.35199426
2025-12-19DXCM66.040.670.61199870
2025-12-22DXCM67.40.660.42178160
2025-12-23DXCM66.850.660.38180092
2025-12-26DXCM67.570.670.85182272
2025-12-29DXCM67.50.670.34180376
2025-12-30DXCM67.080.685.21181699
2025-12-31DXCM66.390.670.89181079
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-02DXCM64.4543.8-9.42.07
2025-12-03DXCM64.8543.8-17.72.07
2025-12-04DXCM65.2843.8-17.42.07
2025-12-05DXCM65.4944.0-20.22.07
2025-12-08DXCM65.6244.0- 2.07
2025-12-09DXCM66.3344.0-13.22.07
2025-12-10DXCM66.3344.0-5.82.07
2025-12-11DXCM68.9444.0-3.72.07
2025-12-12DXCM66.9644.0-52.02.07
2025-12-15DXCM65.7344.0-41.82.07
2025-12-16DXCM65.7343.8-14.12.06
2025-12-17DXCM65.7643.8-32.72.06
2025-12-18DXCM65.8943.8-21.72.06
2025-12-19DXCM66.0443.8-21.82.06
2025-12-22DXCM67.5543.8-1.22.06
2025-12-23DXCM66.8543.8-32.22.06
2025-12-26DXCM67.5743.8-21.62.06
2025-12-29DXCM67.5043.8-24.92.06
2025-12-30DXCM67.0643.8-29.82.06
2025-12-31DXCM66.3843.8-33.82.06
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-02DXCM-0.270.983.49
2025-12-03DXCM-0.270.983.49
2025-12-04DXCM-0.270.983.49
2025-12-05DXCM-0.270.983.49
2025-12-08DXCM-0.271.023.49
2025-12-09DXCM-0.281.023.49
2025-12-10DXCM-0.281.023.39
2025-12-11DXCM-0.281.023.39
2025-12-12DXCM-0.281.023.39
2025-12-15DXCM-0.281.023.39
2025-12-16DXCM-0.271.023.39
2025-12-17DXCM-0.271.023.39
2025-12-18DXCM-0.161.023.39
2025-12-19DXCM-0.111.023.39
2025-12-22DXCM-0.111.983.39
2025-12-23DXCM-0.111.983.39
2025-12-26DXCM-0.111.983.41
2025-12-29DXCM-0.111.893.41
2025-12-30DXCM-0.111.893.41
2025-12-31DXCM-0.111.893.41
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.61

Avg. EPS Est. Current Quarter

0.65

Avg. EPS Est. Next Quarter

0.47

Insider Transactions

-0.11

Institutional Transactions

1.89

Beta

1.49

Average Sales Estimate Current Quarter

1240

Average Sales Estimate Next Quarter

1178

Fair Value

74.24

Quality Score

92

Growth Score

99

Sentiment Score

13

Actual DrawDown %

59.7

Max Drawdown 5-Year %

-66.3

Target Price

86.42

P/E

36.94

Forward P/E

26.84

PEG

1.22

P/S

5.73

P/B

9.49

P/Free Cash Flow

24.38

EPS

1.8

Average EPS Est. Cur. Y​

2.06

EPS Next Y. (Est.)

2.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.96

Relative Volume

0.35

Return on Equity vs Sector %

-0.8

Return on Equity vs Industry %

8.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-33.8
DexCom, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 10200
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
stock quote shares DXCM – DexCom, Inc. Stock Price stock today
news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DXCM – DexCom, Inc. yahoo finance google finance
stock history DXCM – DexCom, Inc. invest stock market
stock prices DXCM premarket after hours
ticker DXCM fair value insiders trading